Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

15.19
Delayed Data
As of Aug 16
 +0.28 / +1.88%
Today’s Change
11.83
Today|||52-Week Range
33.44
-41.87%
Year-to-Date
Why Vanda (VNDA) Might be Well Poised for a Surge
Aug 08 / Zacks.com - Paid Partner Content
Vanda Pharmaceuticals Returns to Profitability in Q2
Aug 05 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close14.91
Today’s open15.06
Day’s range14.81 - 15.30
Volume724,320
Average volume (3 months)756,453
Market cap$809.2M
Data as of 4:00pm ET, 08/16/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-47.11%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+16.98%
P/E ratio28.7
Price/Sales7.18
Price/Book2.89

Competitors

 Today’s
change
Today’s
% change
KURAKura Oncology Inc+0.40+2.29%
ALDRAlder Biopharmaceuti...+0.34+3.68%
EGRXEagle Pharmaceutical...+1.60+2.83%
CYTKCytokinetics Inc+0.77+6.16%
Data as of 4:00pm ET, 08/16/2019

Financials

Next reporting dateNovember 4, 2019
EPS forecast (this quarter)$0.07
Annual revenue (last year)$193.1M
Annual profit (last year)$25.2M
Net profit margin13.05%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
Chief Financial Officer, Treasurer &
Executive VP
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts